Saturday, January 31, 2026

HLB’s Liragratinib: A Game-Changer in Cholangiocarcinoma Treatment Revealed at ASCO GI 2026!

HLB's lirafugratinib shows promise as a precision oncology drug, targeting FGFR2 in cancer treatment. FDA application expected soon.

Bluff or Breakthrough—Doubts Grow Over Trump’s China Claims

Trump's claims of ongoing China negotiations are likely false, aimed at calming markets amid tariff threats, per NYT report.

Tag: cognitive skills

No posts to display

Top News

- Our Sponsors Ad -

Follow us